Emerging drugs for gastro-oesophageal reflux disease.

about

Emerging drugs for gastro-oesophageal reflux disease.

Item

http://www.wikidata.org/entity/Q36150665

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

Emerging drugs for gastro-oesophageal reflux disease.

@ast

Emerging drugs for gastro-oesophageal reflux disease.

@en

type

Item

label

Emerging drugs for gastro-oesophageal reflux disease.

@ast

Emerging drugs for gastro-oesophageal reflux disease.

@en

prefLabel

Emerging drugs for gastro-oesophageal reflux disease.

@ast

Emerging drugs for gastro-oesophageal reflux disease.

@en

P1476

Emerging drugs for gastro-oesophageal reflux disease.

@en

P2093

John De Caestecker

http://www.w3.org/2001/XMLSchema#string

Peter Wurm

http://www.w3.org/2001/XMLSchema#string

P2860

Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification

The rates of common adverse events reported during treatment with proton pump inhibitors used in general practice in England: cohort studies

The esophagogastric junction.

Esomeprazole 20 mg maintains symptom control in endoscopy-negative gastro-oesophageal reflux disease: a controlled trial of 'on-demand' therapy for 6 months.

The effect of cisapride in maintaining symptomatic remission in patients with gastro-oesophageal reflux disease.

The long-lasting effect of TU-199, a novel H+, K(+)-ATPase inhibitor, on gastric acid secretion in dogs.

Tenatoprazole, a novel proton pump inhibitor with a prolonged plasma half-life: effects on intragastric pH and comparison with esomeprazole in healthy volunteers.

Omeprazole v ranitidine for prevention of relapse in reflux oesophagitis. A controlled double blind trial of their efficacy and safety.

The release of 5-hydroxytryptamine in relation to pressure exerted on the intestinal mucosa.

Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication.

P304

457-471

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14728214.10.2.457

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2005-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15934879

http://www.w3.org/2001/XMLSchema#string